SPDR S&P China ETF (NYSEARCA:GXC) Sets New 12-Month High at $79.96

SPDR S&P China ETF (NYSEARCA:GXC)’s stock price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $79.96 and last traded at $78.93, with a volume of 40226 shares trading hands. The stock had previously closed at $73.20.

SPDR S&P China ETF Trading Up 1.9 %

The company has a market capitalization of $538.98 million, a price-to-earnings ratio of 9.52 and a beta of 0.84. The company’s 50 day simple moving average is $67.66 and its 200-day simple moving average is $68.99.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Optimum Investment Advisors increased its position in SPDR S&P China ETF by 20.9% during the first quarter. Optimum Investment Advisors now owns 1,542 shares of the company’s stock worth $101,000 after purchasing an additional 267 shares during the last quarter. Mittelman Wealth Management increased its holdings in shares of SPDR S&P China ETF by 5.2% during the 2nd quarter. Mittelman Wealth Management now owns 7,754 shares of the company’s stock worth $531,000 after buying an additional 382 shares during the last quarter. Simplicity Wealth LLC raised its position in shares of SPDR S&P China ETF by 3.0% in the 2nd quarter. Simplicity Wealth LLC now owns 18,997 shares of the company’s stock worth $1,300,000 after buying an additional 555 shares during the period. Parallel Advisors LLC raised its position in shares of SPDR S&P China ETF by 92.2% in the 4th quarter. Parallel Advisors LLC now owns 2,728 shares of the company’s stock worth $186,000 after buying an additional 1,309 shares during the period. Finally, Hantz Financial Services Inc. acquired a new position in SPDR S&P China ETF in the second quarter valued at $96,000.

SPDR S&P China ETF Company Profile

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.